YU22102A - Novi pirimidin 2,4,6-trion derivati, postupci za njihovu proizvodnju i farmaceutska sredstva koja sadrže ova jedinjenja - Google Patents

Novi pirimidin 2,4,6-trion derivati, postupci za njihovu proizvodnju i farmaceutska sredstva koja sadrže ova jedinjenja

Info

Publication number: YU22102A
Authority: YU; Yugoslavia
Prior art keywords: production; components; pharmaceutical agents; agents containing; new pyrimidine
Prior art date: 1999-10-01

Application number

YU22102A

Other languages

English (en)

Serbo-Croatian (sh)

Inventor

Frank Grams

Hans-Willi Krell

Herbert Leinert

Ernesto Menta

Gerd Zimmermann

Original Assignee

F. Hoffmann-La Roche Ag.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-01

Filing date

2000-09-29

Publication date

2004-11-25

2000-09-29 Application filed by F. Hoffmann-La Roche Ag. filed Critical F. Hoffmann-La Roche Ag.

2004-11-25 Publication of YU22102A publication Critical patent/YU22102A/sh

Links

HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical class O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 title 1
239000008177 pharmaceutical agent Substances 0.000 title 1
101710170181 Metalloproteinase inhibitor Proteins 0.000 abstract 1
125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
239000003475 metalloproteinase inhibitor Substances 0.000 abstract 1
229940126170 metalloproteinase inhibitor Drugs 0.000 abstract 1
-1 phenoxy, phenylthio, phenylsulfinyl Chemical group 0.000 abstract 1
125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 abstract 1
125000003107 substituted aryl group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

YU22102A 1999-10-01 2000-09-29 Novi pirimidin 2,4,6-trion derivati, postupci za njihovu proizvodnju i farmaceutska sredstva koja sadrže ova jedinjenja YU22102A (sh)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP99119506		1999-10-01

Publications (1)

Publication Number	Publication Date
YU22102A true YU22102A (sh)	2004-11-25

Family

ID=8239103

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
YU22102A YU22102A (sh)	1999-10-01	2000-09-29	Novi pirimidin 2,4,6-trion derivati, postupci za njihovu proizvodnju i farmaceutska sredstva koja sadrže ova jedinjenja

Country Status (28)

Country	Link
US (1)	US6498252B1 (fr)
EP (1)	EP1226128B1 (fr)
JP (1)	JP3848160B2 (fr)
KR (1)	KR100459975B1 (fr)
CN (1)	CN1157382C (fr)
AR (1)	AR033651A1 (fr)
AT (1)	ATE289595T1 (fr)
AU (1)	AU768309B2 (fr)
BR (1)	BR0014678A (fr)
CA (1)	CA2385863C (fr)
CO (1)	CO5210860A1 (fr)
CZ (1)	CZ20021535A3 (fr)
DE (1)	DE60018301T2 (fr)
ES (1)	ES2235955T3 (fr)
HU (1)	HUP0202832A3 (fr)
IL (1)	IL148573A0 (fr)
MA (1)	MA26823A1 (fr)
MX (1)	MXPA02003192A (fr)
NO (1)	NO20021380D0 (fr)
NZ (1)	NZ517635A (fr)
PE (1)	PE20010659A1 (fr)
PL (1)	PL202680B1 (fr)
RU (1)	RU2248971C2 (fr)
TR (1)	TR200200858T2 (fr)
UY (1)	UY26362A1 (fr)
WO (1)	WO2001025217A1 (fr)
YU (1)	YU22102A (fr)
ZA (1)	ZA200201754B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6716845B2 (en) *	2001-03-30	2004-04-06	Hoffmann-La Roche Inc.	Barbituric acid derivatives
AU2002346729A1 (en)	2001-12-20	2003-07-09	Bristol-Myers Squibb Company	Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases
WO2004084903A1 (fr) *	2003-03-27	2004-10-07	F. Hoffmann-La Roche Ag	Utilisation d'une trioxopyrimidine pour le traitement et la prevention de l'angiogenese pathologique oculaire
WO2004084902A1 (fr) *	2003-03-28	2004-10-07	F. Hoffmann-La Roche Ag	Utilisation d'une trioxopyrimidine dans le traitement de lesions chroniques
EP1737464B1 (fr) *	2004-04-01	2008-07-23	F. Hoffmann-La Roche AG	Utilisation d'une trioxopyrimidine pour le traitement et la pr vention de maladies inflammatoires bronchiques
AU2005230380B2 (en) *	2004-04-01	2010-09-23	Universite De Liege	Cyclodextrin inclusions complexes of pyrimidine-2,4,6-triones
EP1632489A1 (fr) *	2004-08-24	2006-03-08	University of Liege	Dérivés de 5-(1,1'-Biphényl)-4-yl-5-(4-(4-aminoacylphényl)-pipérazin)-1-yl-pyrimidine-2,4,6-trione comme inhibiteurs de zinc metalloendopeptidase, leur préparation et utilisation.
RU2449994C1 (ru) *	2011-03-10	2012-05-10	Светлана Алексеевна Мещерякова	6-(4-бензилпиперазино)-1,3-диметилурацила дигидрохлорид, проявляющий биологическую активность
RU2598607C1 (ru) *	2015-07-16	2016-09-27	Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный университет" (Астраханский государственный университет)	Способ получения 5-гетарилметиленпиримидин-2,4,6-трионов

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1246743B (de) *	1965-01-12	1967-08-10	Dresden Arzneimittel	Verfahren zur Herstellung von 5-Phenyl-5-piperidinobarbitursaeuren
US4595700A (en)	1984-12-21	1986-06-17	G. D. Searle & Co.	Thiol based collagenase inhibitors
GB8726714D0 (en)	1987-11-14	1987-12-16	Beecham Group Plc	Compounds
GB8827305D0 (en)	1988-11-23	1988-12-29	British Bio Technology	Compounds
US5239078A (en)	1990-11-21	1993-08-24	Glycomed Incorporated	Matrix metalloprotease inhibitors
ES2069833T3 (es)	1990-12-03	1995-05-16	Celltech Ltd	Derivados peptidilicos.
CA2058797A1 (fr)	1991-02-01	1992-08-02	Michael John Broadhurst	Derives d'aminoacide
US5789434A (en)	1994-11-15	1998-08-04	Bayer Corporation	Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
ES2233275T3 (es)	1995-12-08	2005-06-16	Agouron Pharmaceuticals, Inc.	Intermediarios que sirven para la preparacion de inhibidores de metaloproteinasas.
DE19548624A1 (de)	1995-12-23	1997-06-26	Boehringer Mannheim Gmbh	Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US6350786B1 (en) *	1998-09-22	2002-02-26	Hoffmann-La Roche Inc.	Stable complexes of poorly soluble compounds in ionic polymers

2000
- 2000-09-27 AR ARP000105063A patent/AR033651A1/es not_active Application Discontinuation
- 2000-09-27 PE PE2000001013A patent/PE20010659A1/es not_active Application Discontinuation
- 2000-09-27 CO CO00073355A patent/CO5210860A1/es not_active Application Discontinuation
- 2000-09-29 TR TR2002/00858T patent/TR200200858T2/xx unknown
- 2000-09-29 CA CA002385863A patent/CA2385863C/fr not_active Expired - Fee Related
- 2000-09-29 CZ CZ20021535A patent/CZ20021535A3/cs unknown
- 2000-09-29 YU YU22102A patent/YU22102A/sh unknown
- 2000-09-29 DE DE60018301T patent/DE60018301T2/de not_active Expired - Lifetime
- 2000-09-29 AU AU77849/00A patent/AU768309B2/en not_active Ceased
- 2000-09-29 EP EP00967823A patent/EP1226128B1/fr not_active Expired - Lifetime
- 2000-09-29 JP JP2001528163A patent/JP3848160B2/ja not_active Expired - Fee Related
- 2000-09-29 AT AT00967823T patent/ATE289595T1/de not_active IP Right Cessation
- 2000-09-29 WO PCT/EP2000/009535 patent/WO2001025217A1/fr not_active Ceased
- 2000-09-29 UY UY26362A patent/UY26362A1/es not_active Application Discontinuation
- 2000-09-29 BR BR0014678-1A patent/BR0014678A/pt not_active Application Discontinuation
- 2000-09-29 NZ NZ517635A patent/NZ517635A/en unknown
- 2000-09-29 HU HU0202832A patent/HUP0202832A3/hu unknown
- 2000-09-29 MX MXPA02003192A patent/MXPA02003192A/es active IP Right Grant
- 2000-09-29 US US09/675,935 patent/US6498252B1/en not_active Expired - Fee Related
- 2000-09-29 IL IL14857300A patent/IL148573A0/xx unknown
- 2000-09-29 KR KR10-2002-7003979A patent/KR100459975B1/ko not_active Expired - Fee Related
- 2000-09-29 PL PL357385A patent/PL202680B1/pl not_active IP Right Cessation
- 2000-09-29 CN CNB00813006XA patent/CN1157382C/zh not_active Expired - Fee Related
- 2000-09-29 RU RU2002110106/04A patent/RU2248971C2/ru not_active IP Right Cessation
- 2000-09-29 ES ES00967823T patent/ES2235955T3/es not_active Expired - Lifetime
2002
- 2002-03-01 ZA ZA200201754A patent/ZA200201754B/en unknown
- 2002-03-20 NO NO20021380A patent/NO20021380D0/no not_active Application Discontinuation
- 2002-04-01 MA MA26578A patent/MA26823A1/fr unknown

Also Published As

Publication number	Publication date
CO5210860A1 (es)	2002-10-30
CN1374954A (zh)	2002-10-16
WO2001025217A1 (fr)	2001-04-12
HK1050198A1 (en)	2003-06-13
MA26823A1 (fr)	2004-12-20
MXPA02003192A (es)	2002-09-30
PL202680B1 (pl)	2009-07-31
AU768309B2 (en)	2003-12-04
NZ517635A (en)	2003-11-28
IL148573A0 (en)	2002-09-12
HUP0202832A2 (hu)	2003-02-28
HUP0202832A3 (en)	2003-03-28
US6498252B1 (en)	2002-12-24
CZ20021535A3 (cs)	2002-11-13
JP2003511376A (ja)	2003-03-25
ATE289595T1 (de)	2005-03-15
BR0014678A (pt)	2002-07-23
NO20021380L (no)	2002-03-20
NO20021380D0 (no)	2002-03-20
TR200200858T2 (tr)	2002-07-22
DE60018301T2 (de)	2006-04-06
PE20010659A1 (es)	2001-06-20
CA2385863A1 (fr)	2001-04-12
UY26362A1 (es)	2001-04-30
CA2385863C (fr)	2009-04-14
PL357385A1 (en)	2004-07-26
EP1226128A1 (fr)	2002-07-31
ZA200201754B (en)	2003-06-02
JP3848160B2 (ja)	2006-11-22
KR100459975B1 (ko)	2004-12-03
DE60018301D1 (de)	2005-03-31
ES2235955T3 (es)	2005-07-16
CN1157382C (zh)	2004-07-14
AR033651A1 (es)	2004-01-07
AU7784900A (en)	2001-05-10
RU2248971C2 (ru)	2005-03-27
EP1226128B1 (fr)	2005-02-23
KR20020039356A (ko)	2002-05-25

Publication	Publication Date	Title
BG106440A (en)	2002-11-29	Nitrogen-heterocyclic derivatives as nos inhibitors
MXPA03011039A (es)	2004-03-19	Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
AP9901442A0 (en)	1999-03-31	4-(2-Keto-1-benzimidazolinyl) piperidine compounds as orl1-receptor agonists.
EP1334719A3 (fr)	2003-09-24	Pentafluorobenzenesulfonamides et analogues
DK0911333T3 (da)	2002-07-01	Pyrazol [4,3-d]pyrimidinderivater og farmaceutiske præparater, der indeholder disse
EP0931788A3 (fr)	1999-08-04	Inhibiteurs de la métalloprotéinase
HUP0100845A3 (en)	2002-12-28	Hydroxamid acid derivatives as matrix metalloprotease(mmp) inhibitors, process for producing them and pharmaceutical compositions containing them
AU7558900A (en)	2001-04-23	Tetrahydroquinoline derivatives
BG103268A (en)	2000-12-29	Propionic acid derivatives and their application
WO1999064409A3 (fr)	2000-03-02	Derives de benzothiepine-1,1-dioxyde, procedes permettant de les preparer, medicaments contenant lesdits composes et leur utilisation
IL136044A (en)	2005-08-31	2-aminoacetamide derivatives and pharmaceutical compositions containing the same
ES2053609T3 (es)	1994-08-01	Derivados de urea inhibidores de lipoxigenasa.
CA2379026A1 (fr)	2001-01-25	Thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)ones substituees
NO20022558L (no)	2002-05-29	4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor
TR200000586T2 (tr)	2000-09-21	Farmasötik maddelerin oral yoldan biyolojik kullanışlılığının arttırılması için bir yöntem, bileşimler ve kitler.
YU22102A (sh)	2004-11-25	Novi pirimidin 2,4,6-trion derivati, postupci za njihovu proizvodnju i farmaceutska sredstva koja sadrže ova jedinjenja
WO2000016763A3 (fr)	2001-10-11	Agents antipaludeens
BG104712A (en)	2001-02-28	S-substituted 11beta-benzaldoxime-estra-4,9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds
HK1047276A1 (zh)	2003-02-14	作为pde4抑制剂的四氢噻喃2，3-二氮杂萘酮类衍生物
DE60036558D1 (de)	2007-11-08	Phthalazinon-derivate als pde 4 hemmer
MX9708735A (es)	1997-12-31	Benzotiazoles y benzoxazoles, composiciones farmaceuticas que contienen estos compuestos y su uso y proceso para prepararlos.
WO2003080631A3 (fr)	2004-04-15	Inhibiteurs de plasma carboxypeptidase b
HU9301875D0 (en)	1993-09-28	4-imino-quinolines, pharmaceutical preparatives containing them and methods for producing said compounds and preparatives
ES2192789T3 (es)	2003-10-16	Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
TW375525B (en)	1999-12-01	Inhibitors for morphine-like drug induced emesis containing active components (R)-1-ethyl-4-methyl hexahydro-1H-1,4-diazepine derivatives